Executive Overview The landscape of haematological oncology has been fundamentally reshaped by groundbreaking immunotherapies, specifically chimeric antigen receptor (CAR) T-cell therapies and T-cell engaging bispecific antibodies...
Executive Overview With common mental health disorders like anxiety and depression standing as the second leading cause of long-term disability worldwide, primary care nurses (PCNs) find...
Executive Overview For decades, the pursuit of longevity has been shadowed by a physiological paradox. Across numerous scientific studies, reducing calorie intake has reliably extended the lifespan of diverse animal models—ranging from simple fruit flies...
Executive Overview Pancreatic ductal adenocarcinoma (PDAC) remains one of the most formidable adversaries in modern oncology. Characterized by...
Executive Overview Following a landmark FDA de novo authorization, Johnson & Johnson MedTech officially unveiled its next-generation surgical...
